LABORATORY ASPECTS AND CLINICAL SIGNIFICANCE OF BONE TURNOVER MARKERS

Journal Title: Annals of Mechnikov Institute - Year 2019, Vol 0, Issue 3

Abstract

Introduction. With an aging population, there is a marked increase in prevalence of metabolic bone diseases, especially osteoporosis. A serious complication of osteoporosis is non-traumatic bone fractures, which significantly impair quality of life and are associated with comorbid conditions and high mortality. Diseases associated with impaired bone remodeling require timely diagnosis, treatment and monitoring. The consequent public health and socioeconomic burden warrant timely diagnosis, treatment and follow-up of these disorders. Knowing the limitations of radiological techniques, biochemical markers of bone turnover measurements come handy since the changes in their levels readily reflect bone physiology. Material and methods. This paper presents a literature review concerning bone turnover biomarkers with the aim of providing comprehensive information on the applicability of these biomarkers for clinical use. A literature search was conducted in the PubMed, MedLine, Scopus and Embase databases from 1987–2019. Keywords used for search: bone turnover, bone formation, bone resorption, bone biomarkers, biochemical markers of bone turnover. We aimed to determine the clinical effectiveness, test accuracy, reliability, reproducibility and cost-effectiveness of bone turnover markers for monitoring the response to osteoporosis treatment, predicting bone loss and fracture risk, diagnostic of osteoporosis, Paget’s disease, renal osteodystrophy, and certain oncological conditions and rheumatic diseases. Results and discussion. Bone turnover markers are a series of protein or protein derivative biomarkers released during bone remodeling by osteoblasts or osteoclasts. Bone biomarkers typically analyzed in high throughput automated routine laboratories are collagen degradation products, reflecting osteoclast activity and collagenous or non-collagenous proteins produced by the osteoblasts. All these markers can be quantitated well from blood samples, serum being the preferred sample of choice. Although assays for urine examination were developed for quite a few markers, blood sampling generally detours the pre-analytic issues usually involving urine sampling. The most commonly used bone resorption and bone formation markers are discussed in this article. Biochemical markers of bone resorption are mainly different fragments of type I collagen, as well as non-collagen proteins that enter the circulation from the bone matrix resorption zone. The main biochemical indicators used in clinical practice as a criterion for bone tissue resorption are pyridinoline, deoxypyridinoline, tartrate-resistant acid phosphatase, and degradation products of type I collagen - C- and N-terminal telopeptide. All the afore mentioned markers have since been superseded by the more sensitive and specific telopeptides of type I collagen, namely the C-terminal telopeptide (CTx). As compared to the bone resorption biomarkers, there is a larger repertoire of biomarkers of bone formation, reflecting osteoblast activity, namely serum bone-specific alkaline phosphatase, osteocalcin and procollagen type I N-terminal propeptide (PINP). Although produced by the osteoblasts, osteocalcin may be defined as a bone turnover marker reflecting both bone formation and bone resorption, since it is also released from the bone matrix during bone resorption. PINP is more extensively described in literature are compared to the other bone formation biomarkers. Conclusion. Biochemical markers of bone turnover reflect bone homeostasis, i.e., the activity of osteoblasts and osteoclasts in both physiological and pathophysiological conditions. Although quite sensitive to a multitude of exogenous and endogenous pre-analytical factors, bone markers are best used in monitoring anti-osteoporosis therapy efficacy and compliance. Combination of bone mineral density measurement by dual energy x-ray absorptiometry with biochemical markers of bone turnover levels, at least one bone resorption and one bone formation marker, may potentially improve early detection of individuals at increased risk for bone loss and eventually non-traumatic bone fracture. Furthermore, they have widespread clinical utility in osteoporosis, renal osteodystrophy, certain oncological conditions and rheumatic diseases.

Authors and Affiliations

Ye. D. Yehudina, I. Yu. Golovach

Keywords

Related Articles

DEVELOPMENT OF THE POWDER COMPOSITION WITH THE SORBING, ANALGESIC AND ANTIMICROBIAL ACTIVITY BASED ON NATURAL ZEOLITE

Introduction. An active lifestyle, playing sports, participating in hiking trips and various competitions, as well as performing certain types of physical labor may be accompanied by injury. Damage of the skin requires i...

DEVELOPMENT OF THE COMPOSITION AND TECHNOLOGY OF EXTEMPORANEOUS SUPPOSITORIES WITH СLINDAMYCIN AND SEA BUCKTHORN OIL

Introduction. Antibacterial therapy certainly plays an important role in the treatment of these pathologies, although in most cases it causes allergic states, antibiotic resistance of various types of microorganism strai...

COMPARATIVE ASESSMENT OF BACTERIAL EXCRECTION DEGREE DEPENDING FROM SENSIVITY PROFILE OF MYCOBACTERIUM TUBERCULOSIS TO ANTITUBERCULOSIS DRUGS

One of the important part of the epidemiological component of tuberculosis pathomorphosis in modern conditions is the change in important biological properties of the pathogen, not only in the form of increased frequency...

SYNTHESIS OF DYNAMIC RIBOFLAVIN DERIVATIVES AND THE STUDY OF THEIR ABILITY TO UREASE PHOTOINACTIVATION

Introduction. In one patents demonstrated the riboflavin ability to inactivate vaccine strains of viruses and bacteria, as well as cancer cells during the production of vaccines . DNA and RNA within living organisms have...

A STUDY OF ANTIMICROBIAL ACTIVITY OF FOAM-WASHING AGENT SPECIMENS AT ACIDIC PH VALUES

Introduction. It is well-known that any parapharmaceutical substance, in particular, foam-washing agents comprising water in combination with detergents, extracts, water-soluble vitamins, viscosity regulators, pH, etc.,...

Download PDF file
  • EP ID EP645474
  • DOI 10.5281/zenodo.3469393
  • Views 137
  • Downloads 0

How To Cite

Ye. D. Yehudina, I. Yu. Golovach (2019). LABORATORY ASPECTS AND CLINICAL SIGNIFICANCE OF BONE TURNOVER MARKERS. Annals of Mechnikov Institute, 0(3), 7-18. https://europub.co.uk/articles/-A-645474